Press releases

Filter
26 found

Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration

14 Mar 2022

New partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

14 Jul 2021

GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

08 Jan 2021

MMV supports the launch of the new Fight the Fakes Alliance

07 Dec 2020

Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria

24 Apr 2020

Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of P. vivax malaria

30 Oct 2019

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

23 Apr 2019

Kozenis (tafenoquine) approved by the Australian Therapeutic Goods Administration for the radical cure of P. vivax malaria

21 Sep 2018

Severe malaria case fatality reduced by 96% in pilot project in Zambia led by Transaid, MMV and partners

28 Aug 2018

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria

20 Jul 2018

US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria

12 Jul 2018

WHO provides first-ever approval for rectal artesunate product for severe malaria

27 Feb 2018

Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children

25 Jul 2017

Three MMV-supported antimalarials listed as essential medicines

16 Jun 2017

Pyramax® granules (pyronaridine-artesunate) for children added to WHO list of prequalified medicines

20 Apr 2016

Pyramax® Granules becomes first paediatric antimalarial to receive EMA Article 58 positive scientific opinion

20 Nov 2015

Breakthrough Therapy designation for potential new anti-relapse medicine for malaria

20 Dec 2013

Delivery of child-friendly antimalarial hits the 100 million mark

22 Feb 2012

"SMS for Life" rolled-out nationwide in the United Republic of Tanzania

18 Apr 2011

MMV and Novartis launch Coartem® Dispersible

20 Feb 2009

MMV and Novartis launch Coartem® Dispersible in Africa

15 Feb 2009

Unique collaboration launches a new malaria medicine to save millions of children

27 Jan 2009

First-ever comprehensive report on the antimalarials market in Uganda shows how understanding markets can help improve access to medicines

05 Nov 2008

Unforgettable launch of MMV-MOH Uganda pilot

22 Sep 2008

MoH - MMV: Bold intervention being designed in Uganda to deliver subsidized effective antimalarials

01 Oct 2007

Uganda and MMV explore innovative ways to give patients access to life-saving antimalarials

09 May 2007